Compounded tirzepatide in a tablet that dissolves in the mouth without water. No needles, one tablet a day, prescribed online when a licensed provider determines it is appropriate.
First month $199 · then $249/moPlan availability and pricing vary by state. California has its own pricing, confirmed during your assessment.
Start Assessment
Tirzepatide acts on both GIP and GLP-1 receptors, the two incretin pathways studied in clinical research on chronic weight management.
One rapid-dissolve tablet a day. It dissolves in the mouth without water, so there is no injection and no weekly shot to schedule.
A licensed provider in your state reviews your history, prescribes only if appropriate, and adjusts your dose over time based on response and tolerability.
Message your care team anytime with questions. If clinically appropriate, your provider may adjust your dose or treatment plan. Refills are managed online and reviewed by a provider when required or when your treatment changes.
Tirzepatide is a dual GIP and GLP-1 receptor agonist. Here is what that means, pathway by pathway.
GIP (glucose-dependent insulinotropic polypeptide) is an incretin hormone. Tirzepatide acts on the GIP receptor, a pathway involved in insulin signaling and how the body processes nutrients after meals.
GLP-1 is the second incretin pathway. Tirzepatide acts on the GLP-1 receptor, which is involved in appetite signaling and blood-sugar regulation and has been studied extensively in weight-management research.
The RDT format dissolves in the mouth without water. One tablet a day, no needles, built for patients who prefer an oral routine over a weekly injection.
Every plan starts with a provider evaluation. Your provider prescribes only if the treatment is appropriate for you.
A 5-minute online health questionnaire. No appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose questions, refill reviews, and adjustments are handled online when clinically appropriate.
Your assessment takes about 5 minutes. A licensed provider takes it from there.
Start Assessment
Compounded semaglutide acts on GLP-1 receptors. Available when prescribed after provider review.
Compounded tirzepatide acts on both GIP and GLP-1 receptor pathways. Available when prescribed after provider review.